Cardiff Oncology Inc. buy krebskrebs
Start price
16.10.23
/
50%
€1.08
Target price
16.10.24
€1.60
Performance (%)
135.62%
End price
17.10.24
€2.54
Summary
This prediction ended on 17.10.24 with a price of €2.54. The BUY prediction by krebskrebs for Cardiff Oncology Inc. saw massive gains of 135.62%. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Cardiff Oncology Inc. | -12.523% | -12.523% | -24.688% |
| iShares Core DAX® | 0.721% | 4.566% | 24.333% |
| iShares Nasdaq 100 | -0.413% | 1.884% | 8.848% |
| iShares Nikkei 225® | 3.500% | 7.196% | 24.030% |
| iShares S&P 500 | 0.489% | 2.436% | 6.048% |
Comments by krebskrebs for this prediction
In the thread Trovagene diskutieren
Buy mit Kursziel 1,6
In the thread Trading Trovagene
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten

